Research & technology centres - Novo Nordisk
WEBSeattle, Washington. Our research centre in Seattle is focused on digital therapy, data science and artificial intelligence. Furthermore, a dedicated team of device engineers are working with digitalisation and connectivity of medical …
Innovation Hub & Lab - Novo Nordisk
WEBTogether, the Innovation Hub & Lab offer a total of 15-30 students per semester the opportunity to work on their own or Novo Nordisk supplied projects. Possible project topics can come from engineering, data analysis, IT, Robotics - or many other fields. Take action now - contact us!
R&D pipeline - Novo Nordisk
WEBBrowse our entire R&D pipeline by study phase, or select a specific therapy areas. Click on a candidate to access up-to-date trial information.
Novo Nordisk Innovation Hub in Boston, MA | Novo Nordisk U.S.
WEBLearn about the Novo Nordisk Boston Innovation Hub, the headquarters for Global R&D Business Development across all of Novo Nordisk’s therapeutic and technology areas.
News details - Novo Nordisk
WEBSep 26, 2023 · Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases. LAB eN ² will involve institutions including Harvard University, Mass General Brigham, and Beth Israel Deaconess Medical Center.
Novo Nordisk - Wikipedia
WEBNovo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. [5] Its main product is the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. [6]
Valo | Valo Health and Novo Nordisk to collaborate to discover …
WEBNovo Nordisk licenses three preclinical drug discovery programs in cardiovascular diseases discovered and developed by Valo using the Opal Computational Platform™.
Evotec and Novo Nordisk launch LAB eN² to accelerate …
WEBSep 26, 2023 · LAB eN² was created to provide a solution-focused pathway for academic researchers, with a mission to accelerate the translation of their academic discoveries into investigational new drug (“IND”) candidates for cardiometabolic diseases as well as rare blood and rare endocrine disorders.
Pioneering life science innovation - novonordisk-us.com
WEBBuilt on our mission to improve the lives of people living with chronic diseases, the greater Boston U.S. and Denmark R&ED sites are focused on pioneering scientific innovations that redefine the boundaries of what is possible in our quest to improve global health.
Why Novo Nordisk Stock Fell While Eli Lilly and Viking …
WEB1 day ago · That was the dynamic behind Wegovy and Ozempic developer Novo Nordisk 's (NYSE: NVO) Friday stumble on the stock exchange --following its latest news from the lab -- and the gains enjoyed that day ...